Quelicin Injection, Solution
Product Images NDC 0409-6629

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Quelicin (NDC 0409-6629). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hospira, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Quelicin 01

FDA Label Image

Quelicin 02

FDA Label Image

Quelicin 03

This is a warning label for a medication that is intended for intravenous or intramuscular use. The medication contains methylparaben and propylparaben as preservatives. It is a paralyzing agent that can cause respiratory arrest, and artificial respiration equipment must be immediately available. The medication is distributed by Hospira, Inc. and is for prescription use only. The expiration date is also provided.*

FDA Label Image

Quelicin 04

This appears to be a description of a medication product in the form of an injection. The medication is called Succinylcholine Chloride Injection, USP, and it is manufactured in Canada. It is intended for intravenous or intramuscular use and is indicated for dosage, precautions, indications and directions for use. This medication is a paralyzing agent and should be stored in a refrigerator at a temperature of 2° to 8°C (36° to 46°F). The text also includes information about the product's packaging, dosage, and manufacturer.*

FDA Label Image

Quelicin 05

This is a warning label for Rxonly drug NDC0409-6970-10, which is Succinylcholine Chloride Injection, for intravenous use only. It must be diluted before use and may contain HCl and/or NaOH. It is a paralyzing agent and can cause respiratory arrest, therefore, facilities must be available for artificial respiration. It is a sterile and non-pyrogenic drug that should be stored between 2°C to 8°C. The manufacturer is Hospira, Inc. from Lake Forest, IL in the USA.*

FDA Label Image

Quelicin 06

This text is a label for a drug called succinylcholine chloride injection. It warns that the drug is a paralyzing agent that can cause respiratory issues and must be diluted before use. Each mL of the drug contains 100 m of succinylcholine chloride, and it may contain sodium hydroxide and/or hydrochloric acid for pH adjustment. The pH is 36 and the drug is sterile, non-pyrogenic, and for intravenous use. The label provides dosage and administration instructions, NDC number, manufacturer's information and some unreadable characters.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.